Lagatar24 Desk
New Delhi, Dec 29: Joint inspection of the Noida facility of Marion Biotech, was carried out by UP Drug Control and CDSCO team after Uzbekistan on Wednesday claimed that at least 18 children in the country have died after taking Indian cough syrup.
Similar to what was done after 70 children were killed in The Gambia earlier this year, the samples have been sent for contamination testing.
“Joint inspection of Noida facility of Marion Biotech was carried out by UP Drug Control and CDSCO team. Further action is underway. Samples of cough syrup taken from manufacturing premises and sent to Regional Drugs Testing Laboratory, Chandigarh for testing,” said the Union Health minister.
Joint inspection of Noida facility of Marion Biotech, was carried out by UP Drug Control & CDSCO team. Further action underway. Samples of cough syrup taken from manufacturing premises & sent to Regional Drugs Testing Laboratory, Chandigarh for testing: Union Health minister pic.twitter.com/XVk3fZpQHB
— ANI (@ANI) December 29, 2022
Today at the health ministry, the Center is likely to host an interdepartmental meeting.
After Uzbekistan on Wednesday connected the deaths of the 18 youngsters to a cough medication made in India, sources said the Centre had sought a causality status.
ALSO READ: Uzbekistan links deaths of 18 kids to Indian syrup
Months after a similar occurrence was recorded in Gambia, the Uzbek health ministry has claimed that 18 children died there after taking medications made by an Indian pharmaceutical business. In Uzbekistan, Marion Biotech, the company in question, was established in 2012.
The Dok-1 Max syrup, made by Noida-based Marion Biotech, was drunk by the youngsters who died, according to a statement from the Uzbek health ministry. According to the ministry, so far, the syrup has been responsible for the deaths of 18 out of 21 infants with acute respiratory disease.
